Lincoln Pharmaceuticals
537.30
-6.60(-1.21%)
Market Cap₹1,076.20 Cr
PE Ratio12.47
IndustryHealthcare
Company Performance:
1D-1.21%
1M-0.84%
6M-2.58%
1Y-21.90%
5Y+103.72%
View Company Insightsright
Latest news about Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Reports 16.93% Profit Growth in Q1, Reappoints Key Directors Aug 07, 2025
Lincoln Pharmaceuticals reported a 16.93% year-on-year increase in Q1 net profit to Rs. 27.70 crore. Total income rose by 7.39% to Rs. 169.34 crore, while EBITDA grew 17.92% to Rs. 39.08 crore. The company re-appointed key leadership positions, including Mahendra G. Patel as Managing Director. Lincoln aims to achieve Rs. 1,000 crore revenue within three years, targeting 15-18% annual growth. The company plans to expand its global presence from 60+ to 90 countries in 2-3 years. FII stake in the company increased from 3.95% to 5.13% over the past year.
Lincoln Pharma Reports 17% Net Profit Growth in Q1, Targets ₹1,000 Crore Revenue in 3 Years Aug 07, 2025
Lincoln Pharmaceuticals Completes Trial Run at Khatraj Facility, Eyes API Production Jul 02, 2025